Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home—Live Site | Archive Home | Site Map
Archive print banner

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.

Table 2.38
Percent of patients with adverse drug events: anticoagulant related intravenous heparin, United States, 2004 and 2005a
Population group 2005 2004
Exposed Adverse events Percent Standard error Exposed Adverse events Percent Standard error
Total   2,293 298 13.0 0.7 2,244 327 14.6 0.7
Age Under 65 343 48 14.0 1.9 353 35 9.9 1.6
65-74 853 100 11.7 1.1 855 117 13.7 1.2
75-84 832 112 13.5 1.2 798 134 16.8 1.3
85 and over 265 38 14.3 2.2 238 41 17.2 2.4
Gender Male 1,196 139 11.6 0.9 1,191 171 14.4 1.0
Female 1,097 159 14.5 1.1 1,053 156 14.8 1.1
Race White 1,957 255 13.0 0.8 1,904 281 14.8 0.8
Black 233 25 10.7 2.0 230 34 14.8 2.3
Other 103 18 17.5 3.7 110 12 10.9 3.0
Diabetes Yes 884 120 13.6 1.2 819 118 14.4 1.2
No 1,409 178 12.6 0.9 1,425 209 14.7 0.9
Obesity Yes 345 42 12.2 1.8 307 39 12.7 1.9
No 1,948 256 13.1 0.8 1,937 288 14.9 0.8
Cerebrovascular disease Yes 636 93 14.6 1.4 669 102 15.2 1.4
No 1,657 205 12.4 0.8 1,575 225 14.3 0.9
CHF/pulmonary edema Yes 884 150 17.0 1.3 837 151 18.0 1.3
No 1,409 148 10.5 0.8 1,407 176 12.5 0.9
COPD Yes 662 92 13.9 1.3 660 111 16.8 1.5
No 1,631 206 12.6 0.8 1,584 216 13.6 0.9
Smoking Yes 392 59 15.1 1.8 411 64 15.6 1.8
No 1,901 239 12.6 0.8 1,833 263 14.3 0.8
Cancer Yes DNA DNA DNA DNA 463 79 17.1 1.7
No DNA DNA DNA DNA 1,781 248 13.9 0.8
Corticosteroids Yes 2,144 273 12.7 0.7 162 33 20.4 3.2
No 149 25 16.8 3.1 2,082 294 14.1 0.8
Coronary artery disease Yes 1,622 234 14.4 0.9 1,594 251 15.7 0.9
No 671 64 9.5 1.1 650 76 11.7 1.3
Renal disease Yes 854 138 16.2 1.3 702 122 17.4 1.4
No 1,439 160 11.1 0.8 1,542 205 13.3 0.9

a Data include Medicare beneficiaries discharged from January to December.

DNA - Data have not been analyzed.

Key: CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease.

Source: Centers for Medicare & Medicaid Services, Medicare Patient Safety Monitoring System.

 

The information on this page is archived and provided for reference purposes only.

 
AHRQ Advancing Excellence in Health Care